Zobrazeno 1 - 3
of 3
pro vyhledávání: '"913"'
Autor:
Hill GR; Intensive Medicines Monitoring Programme, Department of Preventive and Social Medicine, University of Otago, P.O. Box 913, Dunedin, New Zealand. geraldine.hill@otago.ac.nz, Ashton J, Harrison-Woolrych M
Publikováno v:
Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2007 Nov; Vol. 16 (11), pp. 1217-26.
Autor:
Parkin L; Department of Preventive and Social Medicine, University of Otago, PO Box 913, Dunedin, New Zealand., Skegg DC, Herbison GP, Paul C
Publikováno v:
Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2003 Dec; Vol. 12 (8), pp. 647-52.
Autor:
Coulter DM; Centre for Adverse Reactions Monitoring, Department of Preventive and Social Medicine, Dunedin School of Medicine, University of Otago, PO Box 913, Dunedin, New Zealand. david.coulter@stonebow.otago.ac.nz
Publikováno v:
Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2001 Dec; Vol. 10 (7), pp. 663-7.